Protein A-Based Affinity Chromatography

Process Scale Purification of Antibodies

Volumn , Issue , 2008, Pages 79-102

  Vunnum, Suresh ^a   Vedantham, Ganesh ^a   Hubbard, Brian ^a  

^a AMGEN INC   (United States)

Author keywords

Cost effective manufacturing with growing number of mAb candidates; Protein A based affinity chromatography; Virus removal inactivation

Indexed keywords

EID: 84890602956     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470444894.ch4     Document Type: Chapter

References (62)

1. Farhner, R.L., Knudsen, H., Basey, C., Galan, W., Feuerhelm, D., Vanderlaan, M., Blank, G. (2001). Industrial purification of pharmaceutical antibodies: Develop ment, operation and validation of chromatography processes. Biotechnology and Genetic Engineering Reviews 18, 301-327
2. Shukla, A.A., Hubbard, B., Tressel, T., Guhan, S., Low, D. (2007). Downstream pro cessing of monoclonal antibodies- Application of platform approaches. Journal of Chromatography 848, 28-39
3. Walsh, G. (2007). Engineering Biopharmaceuticals. BioPharm International 20, 64-68
4. Chadd, H.E., Chamow, S.M. (2001). Therapeutic antibody expression technology, Current Opinion in Biotechnology 12,188-194
5. Kelley, K. (2007). Very large scale monoclonal antibody purification: The case for conventional unit operations. Biotechnology Progress 23, 995-1008
6. Hjelm, H., Sjodahl, J., Sjoquist, J. (1975). Immunologically active and structurally similar fragments of protein A from Staphylococcus aureus. European Journal of Biochemistry 57, 395-03
7. Diensenhofer, J. (1981). Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9 and 2.8 A resolution. Biochemistry 20, 2361-2370
8. Li, R., Dowd, V., Stewart, D., Burton, S.J., Lowe, C.R. (1998). Design, synthesis and application of a Protein A mimetic. Nature Biotechnology 16,190-195
9. Roben, P.W., Salem, A.N., Silverman, G.J. (1995). VH3 family antibodies bind domain D of staphylococcal Protein A. Journal of Immunology 154, 6437-6445
10. Starovasnik, M.A., O'Connell, M.P., Fairbrother,W.J., Kelley, R.F. (1999). Antibody variable region binding by staphylococcal Protein A: Thermodynamic analysis and location of the Fv binding site on E -domain. Protein Science 8,1423-1431
11. Ishihara, T., Kadoya, T., Yoshida, H., Tamada, T., Yamamoto, S. (2005). Rational methods for predicting human monoclonal antibodies retention in protein A affin ity chromatography and cation exchange chromatography structure -based chroma tography design for monoclonal antibodies. Journal of Chromatography A 1093, 126-138
12. Sasso, E.H., Silverman, G.J., Mannik, M. (1991). Human IgA and IgG F(ab ')2 that bind to staphylococcal protein A belong to the VH3 subgroup. Journal of Immunol ogy 147,1877-1883
13. Ghose, S., Allen, M., Hubbard, B., Brooks, C., Cramer, S. (2005). Antibody variable region interactions with Protein A: Implications for the development of generic purification processes. Biotechnology and Bioengineering 92, 665-673
14. Burton, D.R. (1985). Immunoglobulin G: Functional sites. Molecular Immunology 22,161-206
15. Leatherbarrow, R., Dwek, R. (1983). The effect of glycosylation on the binding of mouse IgG to staphylococcal protein A. FEBS Letters 164, 227-230
16. Jungbauer, A., Hahn, R. (2004). Engineering protein A affinity chromatography. Current Opinion in Drug Discovery and Development 7, 248-256
17. Ghose, S., Hubbard, B., Cramer, S.M. (2007). Binding capacity differences for anti bodies and Fc -fusion proteins on Protein A chromatographic materials, Biotechnol ogy and Bio engineering 96,768-779
18. Carter-Franklin, J.N., Victa, C., McDonald, P., Fahrner, R. (2007). Fragments of protein A eluted during protein A affinity chromatography. Journal of Chromatog- raphy A 1163, 105-111
19. McCue, J.T., Kemp, G., Low, D., Quinones-Garcia, I. (2003). Evaluation of protein -A chromatography media. Journal of Chromatography A 989,139-153
20. rProtein A Sepharose FF, data file 18-1113-94 AD, GEHealthcare
21. MabSelect, data file 18-1149-94 AE, GEHealthcare
22. MabSelect Xtra: Recombinant Protein A-based high capacity medium data file 11-0011-57 AB, GEHealthcare
23. MabSelect SuRe: Alkali-Stabilized protein A derived medium for capture of mono clonal antibodies, data file 11-0011-65 AB, GEHealthcare
24. Braisted, A.C., Wells, J.A. (1996). Minimizing a binding domain from protein A. Proceedings of the National Academy of Sciences of the United States of America 93, 5688-5692
25. Gulich, S., Uhlen, M., Hober, S. (2000). Protein engineering of an IgG -binding domain allows milder elution conditions during affinity chromatography. Journal of Biotechnology 76, 233-244
26. Hahn, R., Schlegel, R, Jungbauer, A. (2003). Comparison of protein A affinity sor- bents. Journal of Chromatography B 790, 35-51
27. Swinnen, K., Krul, A., Van Goidsenhoven, I., Van Tichelt, N., Roosen, A., Van Houdt, K. (2007). Performance comparison of protein A affinity resins for the purification of monoclonal antibodies. Journal of Chromatography B 848, 97-107
28. Schwartz, L. (1990). Immunomodulatory properties of Protein A. In Boyle, M. (ed.) Bacterial Immunoglobulin -Binding Proteins, Vol. 2, Academic Press, San Diego, CA, pp. 309-318
29. ProSep A High Capacity: The throughput and capacity leader for Monoclonal Antibody capture, TB1010EN00, 2002, Millipore
30. Fahrner, R.L., Whitney, D.H., Vanderlaan, M., Blank, G.S. (1999). Performance comparison of Protein A affinity chromatography sorbents for purifying recombi nant monoclonal antibodies. Biotechnology and Applied Biochemistry 30, 121-128
31. Fahrner, R.L., Iyer, H.V., Blank, G.S. (1999). The optimal fl ow rate and column length for maximum production rate of protein A chromatography. Bioprocess Engineering 21, 287-292
32. Hahn, R., Bauerhansl, P., Shimahara, K., Wizniewski, C., Tscheliessnig, A., Jungbauer, A. (2005). Comparison of protein A affinity sorbents: II. Mass transfer properties. Journal of Chromatography A 1093, 98-110
33. Rohrbach, P., Broders, O., Toleikis, L., Stefan, D. (2003).Therapeutic antibodies and antibody fusion proteins. Biotechnology and Genetic Engineering Reviews 20, 137-163
34. Gagnon, P. (1996). Protein A affinity chromatography purification. In Tools for Monoclonal Antibodies, Validated BioSystems, Tucson, AZ, chapter 9, pp. 155-190
35. Ghose, S., Nagrath, D., Hubbard, B., Brooks, C., Cramer, S.M. (2004). Use and optimization of a dual fl owrate loading strategy to maximize throughput in Protein A affinity chromatography. Biotechnology Progress 20, 830-840
36. Hinkley, P.J., Hubbard, B., Shukla, A. (2003). Scale-up and productivity optimization for Protein A chromatography. Poster presented at the ACS Conference, New York, NY, September 11, 2003
37. Millipore Technical Brief: Increasing purity on ProSep -vA affinity chromatography media using an intermediate wash step. TB1026EN00, 2006
38. Breece, T.N., Fahrner, R.L., Gorrell, J.R., Lazzareschi, K.P. (2005). Protein purifica tion. US Patent #6,870,034
39. Shukla, A., Hinkley, P., Gupta, P., Yigzaw, Y., Hubbard, B. (2005). Strategies to address aggregation during Protein A chromatography. Bioprocess International 3, 36-3
40. Seed, B. (1998). Affinity purification methods using imidazole elution. US Patent #5,726,293
41. Arakawa, T., Philo, J., Tsumoto, K., Yumioka, R., Ejima, D. (2004). Elution of anti bodies from a Protein A column by aqueous arginine solutions. Protein Expression and Purification 36, 244-248
42. Brorson, K., Brown, I, Hamilton, E., Stein, K.E. (2003). Identification of protein A media performance attributes that can be monitored as surrogates for retrovirus clearance during extended re -use. Journal of Chromatography A 989,155-163
43. Girot, P., Moroux, Y., Pouradier, X., Nguyen, C., Boschetti, E. (1990). Composite affinity sorbents and their cleaning in place. Journal of Chromatography 510, 213-223
44. Hale, G., Drumm, A., Harrison, P., Phillips, I (1994). Repeated cleaning of protein A affinity column with sodium hydroxide. Journal of Immunological Methods 171, 15-21
45. Johansson, H.J., Bergenstrahle, A., Rodrigo, G., Oberg, K. (1998).The use of NaOH for CIP of rProtein A media: A 300 cycle study.Poster presented at the ACS Con ference, Boston, MA, 1998
46. Yigzaw, Y, Piper, R., Tran, M., Shukla, A.A. (2006). Exploitation of the adsorptive properties of depth filters for HCP removal during monoclonal antibody purifica tion. Biotechnology Progress 22, 288-296
47. Tobler, S., Noyes, A., Rajeswski, I, Shpritzer, R., Piacenza, W.,Tannatt,W., Coffman, I, Vunnum, S., Kelley, B. (2006). Analysis of Protein A peak precipitates and approaches to reduce peak turbidity. Poster presented the ACS Conference, San Francisco, CA, 2006
48. Coffman, J.L, Shpritzer, R., Vicik, S. (2006). Flocculation of antibody -producing mammalian cells with precipitating mixtures of cationic and anionic solutions. Poster presented at the XII Recovery of Biologics Conference, Tucson, AZ, 2006
49. Menon, M. (2006). Use of fl occulants to improve cell culture harvest clarification and product capture steps. Poster presented at the XII Recovery of Biologics Con ference, Tucson, AZ, 2006
50. Romero, J.K., Chrostowski, J., Vilmorin, P., Smelko, J. (2007). Disc stack centrifuga- tion 2 L to 20,000 L scale-up evaluation for mammalian cell clarification: Optimiza tion of bioreactor harvest conditions for combined cell removal and mAb purification capabilities. Presented at the BioProcess International Conference, Boston, MA, 2007
51. FDA (1998). FDA Q5A Guidance Document: Viral Safety Evaluation of Biotech nology Products Derived from Cell Lines of Human or Animal Origin. Federal Register 63, 51074. http://www.fda.gov/cder/guidance/Q5A-fnl.pdf, accessed September, 1998
52. Brorson, K., Krejci, S., Lee, K., Hamilton, E., Stein, K., Xu, Y. (2003). Bracketed generic inactivation of rodent retroviruses by low pH treatment for monoclonal antibodies and recombinent proteins. Biotechnology and Bioengineering 82, 321-329
53. st century. Bio- Pharm International 16, 50-57
54. Abujoub, A., Oty, G., Shepherd, A. (2001). Factors affecting the kinetics of xeno- tropic murine leukemia virus inactivation by low pH: The role of pH range, tem perature, protein concentration and product. IBC Conference. Presented at the PDA/FDA Viral Clearance Forum, Bethesda, MD, 2001
55. Reindal, K. (2001). Generic approach to viral clearance studies. Presented at PDA/ FDA Viral Clearance Forum, Bethesda, MD, 2001
56. Felice, C., Barnthouse, K., Reinert, I, Meyers, A., Wojciechowski, P. (2003). An evaluation of TSE clearance in a monoclonal antibody purification process. Recov ery of Biological Products XI, Banff, Alberta, Canada, 2003
57. Farshid, M., Taffs, R.E., Scott, D., Asher, D.M., Brorson, K. (2005).The clearance of viruses and transmissible spongiform encephalopathy agents from biologicals. Current Opinion in Biotechnology 16, 561-567
58. Breece, T.N., Gilkerson, E., Schmelzer, C. (2002). Validation of large -scale chro- matographic processes. BioPharm International 15, 35-3
59. Follman, D., Fahrner, R.L. (2004). Factorial screening of antibody purification pro cesses using three chromatography steps without protein A. Journal of Chromatog- raphy A 1024, 79-85
60. Schwartz, W., Judd, D., Wysocki, M., Guerrier, L., Birck-Wilson, E., Boschetti, E. (2001). Comparison of hydrophobic charge induction chromatography with affinity chromatography on Protein A for harvest and purification of antibodies. Journal of Chromatography A 908, 251-263
61. Ghose, S., Hubbard, B., Cramer, S.M. (2006). Evaluation and comparison of alterna tives to Protein A chromatography mimetic and hydrophobic charge induction chromatographic stationary phases. Journal of Chromatography A 1122,144-152
62. Bisschops, M. (2007). BioSMB: Scaled down mAb Capture in a disposable-format continuous, multi-column chromatography process. Presented at the BioProcess International Conference, Boston, MA, 2007